Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of his Department's proposed reforms to the Medicines and Healthcare Products Regulatory Agency on the incentives for international pharmaceutical companies to approach the UK for regulatory approval of their products in the first instance.

There are no proposed reforms to the Medicines and Healthcare products Regulatory Agency (MHRA), therefore no assessment can be made on that basis. However, as set out in the Life Sciences Vision the MHRA is recognised as a global leader and plays a fundamental role in shaping global standards. As an independent sovereign regulator MHRA is able to act with agility to allow safe and timely market access for vaccines, medicines, and technologies to safeguard the health of the United Kingdom population.